Skip to Main Content

STAT Breakthrough Summit

Here you’ll find coverage of the STAT 2024 Breakthrough Summit West, a May 16 event combining a virtual and San Francisco audience, plus archived coverage of previous summit events.

Latest

Sponsored Insight CZI

AI, virtual cells, and a revolutionary platform for biology

Sponsored Insight Gilead HIV

What will it take to end HIV?

Sponsored Insight GENENTECH, A MEMBER OF THE ROCHE GROUP

Making drug discovery more iterative with AI

Health tech Casey Ross and Matthew Herper

STAT Plus: AI & drug discovery: A biotech CEO, a scientist, and a venture capitalist separate hype from reality

Health Deborah Balthazar

Black women founders offer health tech solutions to combat Black maternal mortality

In the Lab Megan Molteni

STAT Plus: ChatGPT for genomes: introducing a CRISPR-designing generative AI

Health tech Lizzy Lawrence

STAT Plus: Venture capitalist Bob Kocher on generative AI startups, Change Healthcare cyberattack

Health tech Brittany Trang

STAT Plus: Wearable devices generate powerful data but it’s not useful to doctors, yet

All Coverage

Biotech Elaine Chen

STAT Plus: Amid acquisition speculation, Cytokinetics CEO stresses company can launch heart drug on its own

In the Lab Angus Chen

STAT Plus: Data integrity watchdogs call for stronger safeguards in scientific journals

advertisement

The Readout LOUD Allison DeAngelis and Adam Feuerstein

STAT Plus: Live! From the STAT Breakthrough Summit West

Health Lev Facher

Amid backlash to harm reduction, addiction experts warn against reprising ‘war on drugs’

Sponsored Insight Novartis

Putting the patient in the room

Sponsored Insight AstraZeneca

How AI is advancing cancer care and closing treatment gaps

Biotech Jason Mast

STAT Plus: Patient advocates clash over wisdom of ‘approving drugs faster and faster’

Biotech Allison DeAngelis and Mario Aguilar

STAT Plus: How biotech investors spot opportunity when stocks are down — and up

Biotech Elizabeth Cooney

STAT Plus: Drug development was once a marathon. New tools and timelines are turning it into a sprint

STAT Madness Theresa Gaffney

Male birth control research wins audience over at STAT Madness event

The Readout LOUD Damian Garde, Allison DeAngelis, and Adam Feuerstein

Live! From the STAT Breakthrough Summit East

Health Lev Facher

STAT Plus: Ibogaine, the psychedelic, unlikely to receive approval as opioid treatment, says top addiction researcher

Biotech Damian Garde

STAT Plus: Regeneron’s plot to ‘cure’ allergies

Biotech Annalisa Merelli

STAT Plus: Getting CRISPR treatments to patients remains a major challenge. Could lab-developed tests help?

Biotech Andrew Joseph

STAT Plus: Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Pharma Ambar Castillo

STAT Plus: ‘Robbing Peter to pay Paul’: Obesity experts debate risks of new weight loss drugs

Health tech Brittany Trang

STAT Plus: 4 ways the health care system should shift its thinking on AI, according to experts

Biotech Jason Mast

STAT Plus: Doudna talks cost, access issues looming over first CRISPR therapy

Biotech Bob Herman

STAT Plus: Gilead foresees more growth in its HIV drugs

Biotech Brittany Trang

STAT Plus: ‘Are we better off with the information?’: Experts spar over the benefits of liquid biopsy to catch cancer

Biotech Matthew Herper

STAT Plus: A new list ranks large pharmaceutical companies by research and development